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Uncertainty of fast biological radiation dose assessment for emergency response 
scenarios 
Purpose Reliable dose estimation is an important factor in appropriate 
dosimetric triage categorization of exposed individuals to support radiation 
emergency response.  
Materials and Methods Following work done under the EU FP7 
MULTIBIODOSE and RENEB projects, formal methods for defining 
uncertainties on biological dose estimates are compared using simulated and real 
data from recent exercises.  
Results The results demonstrate that a Bayesian method of uncertainty 
assessment is the most appropriate, even in the absence of detailed prior 
information. The relative accuracy and relevance of techniques for calculating 
uncertainty and combining assay results to produce single dose and uncertainty 
estimates is further discussed.  
Conclusions Finally, it is demonstrated that whatever uncertainty estimation 
method is employed, ignoring the uncertainty on fast dose assessments can have 
an important impact on rapid biodosimetric categorization. 
 
Introduction 
Biological markers of radiation exposure are important tools for determining radiation 
doses for exposed or suspected exposed individuals following a mass-casualty radiation 
accident or incident (Swartz et al., 2014). Members of the European Union (EU) 7th 
Framework Programme (FP7) (Realising the European Network of Biodosimetry 
(RENEB) retrospective dosimetry mutual assistance network and European Radiation 
Dosimetry Group (EURADOS) Working Group (WG) 10 on retrospective dosimetry 
have been developing and validating existing and new physical and biological exposure 
  
markers, to ensure that network members are ready to provide retrospective dosimetry 
to support emergency responders in the event of a large scale radiological event. Rapid 
biodosimetric categorization of individuals suspected of being exposed to ionising 
radiation is based on dose information from the individual RENEB assays - the 
biological techniques based on scoring of dicentrics (DIC), micronuclei (MN), gamma-
H2AX foci, prematurely condensed chromosomes (PCC), and the physical techniques 
of electron paramagnetic resonance (EPR) and optically stimulated luminescence (OSL) 
(Kulka et al., 2015; 2016). 
In the initial phase of a response to a mass casualty exposure scenario, triage of 
individuals for medical purposes is generally based solely on where individuals were 
and for how long together with the presence/absence of prodromal signs. However, the 
stress and uncertainty following such an event and the inherent inter-individual 
variability mean that these criteria are known to be unreliable. Thus the need for more 
quantitative secondary triage methods, which can be provided by the biodosimetry 
community, is well documented (Sullivan et al., 2013).  Although the main focus of 
large scale accident biodosimetry is rapid dose estimation to assist emergency 
responders in identifying those in greatest need of medical intervention, it is important 
to keep in mind that all biological and physical methods of retrospective dosimetry 
result in dose estimates with non-zero uncertainties, and the incertitude associated with 
biological dose estimates can be considerable. Methods of uncertainty estimation for 
screening doses and biodosimetry triage or rapid categorization were previously 
developed under the EU FP7 multi-disciplinary biodosimetric tools to manage high 
scale radiological casualties (MULTIBIODOSE) project (Jaworska et al., 2015). Under 
RENEB, work has continued to refine the biological and statistical aspects of the assays 
  
to ensure readiness of the community to respond to a radiological or nuclear accident or 
incident (Barnard et al., 2015; Kulka et al., 2015; Abend et al., 2016).  
In this paper, the results of some recent work to refine the statistical aspects of 
the dosimetry methods are described, focusing on formal assessment of the uncertainties 
associated with rapid dose estimates and the associated categorization of individuals to 
support medical triage. Simulations based on recent data have been used to test and 
compare uncertainty estimation methods relying on the International Organization for 
Standardization (ISO) standard method of propagation of errors (ISO19238, 2014), a 
simplification of this method ignoring covariances between experimental factors used 
under MULTIBIODOSE (Ainsbury et al., 2014), Merkle’s method for combining the 
errors on the yield and curve (Merkle, 1983; IAEA, 2011) the IAEA simplification of 
this based on the exact Poisson error (IAEA, 2011) and a Bayesian method to assess 
radiation dose (Higueras et al., 2015). Where appropriate, the methods have been 
applied to data from the dicentric, gamma-H2AX, micronucleus and PCC assays. The 
probability of correct rapid categorization (< 1 Gy; 1 – 2 Gy; 2+ Gy) given the 
magnitude of the associated uncertainties was then tested using data from recent 
MULTIBIODOSE and RENEB inter-comparison exercises and the RENEB 'table-top' 
rapid biodosimetric categorization exercise, which amongst other things has resulted in 
creation of a formal expert consensus for fast assessment (Brzozowska et al., 2016). 
Finally, the potential for and implications of inclusion of an assessment of uncertainty 
into rapid biodosimetric information provided to emergency responders or other 
medical professionals is considered.  
  
Materials and methods 
Data and assumptions 
For the dicentric assay, the calibration data were taken from the publication of 
Barquinero and colleagues (1995) which is analysed in detailed examples in the 
International Atomic Energy Agency (IAEA) manual (2011). The data analysed for 
magnitude of uncertainties come from the DIC data collected during the in vitro 
exposure simulations carried out under the MULTIBIODOSE and RENEB projects 
(Romm et al., 2014; Oestreicher et al., 2016). Uncertainties were calculated based on 
both whole body, acute, high dose rate (HDR) exposures and chronic/low dose rate 
(LDR) curves and data. The MN calibration curve data and test data were taken from 
Thierens et al. (2014), representing data collected under the MULTIBIODOSE project. 
Uncertainties were again calculated based on both HDR and LDR curves and data. For 
LDR exposures for the dic and MN assays, a total exposure time of 10 hours and a 
repair time, t0, of 2 hours was assumed.  
The gamma-H2AX curve data were taken from the 4 and 24 hour calibration 
curves established at Public Health England (PHE) as part of the MULTIBIODOSE 
project (Rothkamm et al., 2013) and the test data were taken from the recent RENEB 
inter-comparison (Barnard et al., 2015). For the gamma-H2AX assay, it is 
recommended to apply at least one positive control to produce a reference sample ratio 
value, representing the ratio of the measured response at the chosen dose to the 
calibration curve response at the corresponding dose value. For this work, a relative 
reference sample ratio (r) value of 1 and reference sample standard deviation (SD) of 
sqrt(1) (a Poisson assumption) was assumed. The PCC curve and test data were taken 
from recent work done under RENEB (Terzoudi et al., 2016) for simulated high dose 
rate acute exposures.  
  
Test data for all assays and scenarios were also taken from the RENEB accident 
simulation (Brzozowska et al., 2016), in order to test the impact of including 
uncertainty estimation on rapid biodosimetry categorization. Uncertainty calculations 
were based on number of aberrations observed in 50 cells for all assays, corresponding 
to the recommended methods for fast dose assessment purposes.  
Uncertainty analysis methods 
The uncertainty associated with each assay/scenario was calculated as follows: 
1.  ISO propagation of errors (‘ISO method’) 
In the usual scenario, i.e. that yield of dicentrics/micronuclei and dose follow a linear-
quadratic relationship, dose is calculated using equation (1): 
 𝐷 =  
−𝛼+ √𝛼2±4𝛽(𝑦−𝐴)
2𝛽
 (1) 
where D is dose, A is the (fitted) background rate, 𝛼 is the linear coefficient, 𝛽 is the 
quadratic coefficient, and 𝑦 is the measured yield of dicentrics per cell. As discussed in 
the ISO standard (2014), the procedure for estimating the uncertainty on the dose is 
based on the general case: 
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For the LDR exposure scenario, the relationship between the yield and dose is 
also reliant on the total exposure (t) and repair time (t0), and thus β in equation (1) is 
replaced with the Lea and Catcheside function β’ (IAEA, 2011):  
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This leads to the addition of corresponding components based on t and t0 in 
equation (2). 
For the gamma-H2AX assay, the situation is simplified in that the dose response 
is linear, but according to RENEB and MULTIBIODOSE procedures, at least one 
positive control or reference sample (r) must be included in each analysis to ensure that 
the applied calibration curve is suitable for the data being analysed. As such, equation 
(1) is modified to give: 
𝐷 =
𝑦−𝐴
𝛼
. 𝑟      (4) 
 The corresponding equation (2) for the H2AX assay thus contains partial 
derivative components for y, A, 𝛼, and r and all the corresponding covariance (cov) 
components.  
For the PCC assay, the relationship between dose and excess PCC fragments is 
linear and thus equation (4) can be applied in the absence of the reference sample (r) 
component and the corresponding uncertainty calculation only requires partial 
derivatives for y, A, 𝛼 and the corresponding covariance components. 
2. MULTIBIODOSE simplification (‘MBD method’)  
Given that the uncertainties associated with fast biodosimetry are large and that the 
relative magnitude of the covariance components is very small, under 
MULTIBIODOSE it was suggested that the equations above could be simplified for 
uncertainty calculation for fast assessment purposes by ignoring the covariance 
components entirely: 
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3. Merkle’s method for consideration of Poisson error on yield and error in 
calibration curve coefficients (‘Merkle method’)        
The IAEA manual (2011), which is used by many members of the retrospective 
dosimetry community, presents Merkle’s proposals (1983) as the simplest method for 
calculation of uncertainties on dose estimates. The method is described in detail in the 
manual (IAEA, 2011), however, in brief, it relies on calculation of the upper and lower 
95% confidence limits on the yield (yyu and yyl) according to the Poisson distribution, 
using equations (6) and (7) respectively: 
𝑦𝑦𝑢 =
0.5∗𝜒𝑞(0.025,2∗𝑦∗𝑛+2)
𝑛
     (6) 
𝑦𝑦𝑙 =
0.5∗𝜒𝑞(0.975,2∗𝑦∗𝑛)
𝑛
     (7) 
where χq is the quantile function of the Chi-squared distribution for percentage point, 
degrees of freedom of 2yn+2 for yyu or 2yn for  yyl. 
Calculation of the upper and lower confidence limits on the curve (ycu(D) and ycl(D)) is 
then carried out according to equation (8):   
𝑦𝑐𝑢/𝑐𝑙(𝐷) = 𝐴 + 𝛼𝐷 + 𝛽𝐷
2 ± 𝑅√𝑠𝐴
2 + 𝑠𝛼2𝐷2 + 𝑠𝛽
2𝐷4 + 2𝑠𝐴,𝛼𝐷 + 2𝑠𝐴,𝛽𝐷2 + 2𝑠𝛼,𝛽𝐷3.  
 (8) 
where 𝑠𝑥
2 is the variance of x and 𝑠𝑥,𝑧 the covariance of x and z. The regression 
confidence factor 𝑅2 is the 95% confidence limit of the Chi-squared distribution with 2 
or 3 degrees of freedom for linear or linear-quadratic fits, respectively. I.e., for 95% 
confidence limits, R = 2.45 or R = 2.80 respectively. Finally, determine the dose at 
which the yield yyl intersects with ycu(D) to give the lower confidence limit on the dose, 
and determine the dose at which yyu  intersects with ycl(D) to give the upper confidence 
limit on the dose.  
4. IAEA simplification (‘IAEA’) 
  
In addition to the above, several methods for calculating the confidence limits on 
estimated doses, usually characterised as the 95% confidence limits, are recommended 
and discussed in the IAEA manual for biodosimetry (2011). As the dominant 
contribution to uncertainty in rapid categorization mode is likely to be the Poisson error 
on the number of scored aberrations, the simplified method of calculating uncertainty 
based on the exact Poisson 95% confidence limits has been implemented here for 
comparison with the alternative methods. The upper (yyu) and lower (yyl) Poisson 
confidence limits on the yield are calculated as above.  The limits yyu and yyl are then 
converted to confidence limits on dose by substituting these values into equation (1). 
5. Bayesian calibrative density calculations (Bayes) 
A Bayesian approach to biodosimetry data analysis and dose estimation has been 
gaining popularity in recent years, with several new methods appearing in the recent 
literature, including the approach of Higueras and colleagues (2015) who developed a 
new inverse regression model applied to radiation biodosimetry using Poisson or 
compound Poisson responses, which produces a posterior dose distribution or 
calibrative density. An R programming language (R, 2014) library has recently been 
produced to reproduce the methodology (Morina et al., 2015).  
Calculations and simulations 
The R programming language (R, 2014) core functions and radir library (Morina et al., 
2015) were used to calculate calibration curve coefficients and covariance matrices and 
dose and uncertainty estimations based on the above three methods.  
Next, based on the calibration data of Barquinero et al. (1995), dicentric samples 
were simulated for several fictitious scenarios, simulating numbers of dicentric 
aberrations caused by irradiations of 0.5 Gy in 50 and 2002 lymphocytes, 1.5 Gy in 50 
  
and 562 cells, and 3 Gy in 50 and 193 cells. These doses and their dicentric distributions 
are taken from the calibration data, so at each simulated scenario the absorbed dose 
sample, the test data, is not included in the calibration data set, thus simulating the level 
of uncertainty implicit in biological dose estimations. The simulations were generated 
by non-parametric bootstrap methodology, simulating samples with replacement from 
the original one. At each iteration, the calibration and test data are simulated, then the 
fitted dose-response coefficients, the variance-covariance matrix and the sample sum of 
the test data are collected. Finally the dose estimation uncertainty was calculated using 
the five different methods analysed in this manuscript, and it was checked to see 
whether the confidence (credible) interval contained the absorbed dose. The simulations 
were performed for 95% confidence (credible) regions, so the value closest to 95% 
indicates the most accurate estimation method. 
Following calculation of the uncertainties using the data as described above for 
each of the ISO, MULTIBIODOSE, Merkle and IAEA and Bayesian methodologies, 
probabilities of correct rapid categorization as either < 1 Gy; 1 – 2 Gy or 2+ Gy were 
then calculated using the cumulative standard normal distribution for doses in 
increments of 0.05 Gy from 0 – 3 Gy (results not reported), for each assay/exposure 
scenario, or using radir to implement the Bayesian methodology of Higueras et al. 
(2015). For the calibrative density calculations, the absorbed dose prior distribution was 
assumed to be uniform; the calibration curve information was collected in a univariate 
prior assumed to be gamma distributed. 
The dosimetry data were then taken from the recent RENEB table top exercise 
to estimate the impact of the findings on fast dose assessment in a real accident. The 
mean uncertainty reported in rapid categorization mode in the publications listed above 
was calculated for the relevant exposure scenarios at doses of 0, 0.5, 1, 1.5,2 and 2.5 Gy 
  
and applied to the DIC, MN, gamma-H2AX and PCC assay data (doses only) from the 
RENEB table top exercise (Brzozowska et al., 2016). The standard normal distribution 
was then used to calculate the probability of correct categorization for each data point 
(consisting of the mean of the dosimetry results from each of the assays) from the 
RENEB exercise, in order to test the impact of uncertainty on the success of the rapid 
dose assessment and categorization procedure. For instance, a nominal dose of just 
above 1 Gy might, in fact, have a larger probability given the applied uncertainty of 
being in the < 1 Gy category than the ‘correct’ 1-2 Gy category. 
Results 
The fitted calibration coefficients used for the four assays are given in Table I. 
 
<TABLE I HERE> 
Table II describes the results of the simulations of coverage of the various uncertainty 
characterisation methods applied to the dicentric assay. 
 
<TABLE II HERE> 
 
Figure 1 illustrates the relative magnitude of the uncertainties calculated for the 
MULTIBIODOSE methodology, for doses of 0, 0.5, 1, 1.5, 2 and 2.5 Gy. Table III 
gives the probability based on the cumulative normal distribution or the Bayesian 
probability that, given the magnitude of the uncertainties calculated using each method, 
the categories were correct. Figure 2 illustrates one example from Table III – the 
posterior dose distribution (calibrative density) for a simulated HDR exposure resulting 
  
in a yield of 0.17 dicentrics per cell to give a nominal dose of 1.5 Gy. The expected 
dose is 1.53 +/- 0.28. The probability of being in between 1 and 2 Gy (shaded in grey) is 
calculated as 0.917. 
 
<FIGURE 1 HERE> 
<FIGURE 2 HERE> 
 
<TABLE III HERE> 
 
The average magnitude of the uncertainties was then applied to the RENEB 
table top exercise data before the cumulative normal distribution was used to calculate 
the probability that the dose fell in each of the three rapid assessment categories: < 1 
Gy, 1 – 2 Gy or 2+ Gy. The category that had the highest probability was assigned in 
each case. The results were then compared to the category assignments based on dose 
alone. Overall, less than 2% of the responses based on the probabilities were assigned to 
categories lower than expected, and these were those responses corresponding to doses 
just above 1 Gy. For instance, a dose of 1.05 Gy has a standard deviation of 
approximately 0.68 Gy (mean SD from the 4 assays combined). This means that there is 
a cumulative probability of 0.471 that the actual exposure was less than 1 Gy and a 
probability of 0.447 that the exposure fell between 1 and 2 Gy. Thus, incorporating the 
uncertainty means that this nominal dose of 1.05 Gy has a slightly higher probability of 
being incorrectly assigned to the < 1 Gy category compared to the correct 1 – 2 Gy 
category. Applying the same procedure, 11% of the RENEB samples were categorised 
as being too high: these are doses above approximately 1.65 Gy (and below 2 Gy) for 
  
which the width of the normal distribution around the dose meant that they had a higher 
probability of being in the 1 – 2 Gy category.  
Figure 3 illustrates in full the variation in probability that a dose is placed in the 
correct category < 1 Gy, 1 – 2 Gy or 2+ Gy with dose. 
 
<FIGURE 3 HERE>  
Discussion 
Retrospective dosimetry to assist in triage of exposed or suspected exposed individuals 
following a large scale radiation accident or incident implies provision of dose estimates 
which are as accurate as possible within the shortest time possible. Biodosimetry is a 
recognised method to support triage and the large amount of work completed under the 
RENEB project has ensured that EU laboratories maintain emergency response 
readiness (Kulka et al., 2016). The RENEB ‘toolkit’ contains a number of assays, 
including the four assessed in this paper – further details of which can be found in 
Oestreicher et al. (2016) for the dicentric assay; Depuydt et al. (2016) for the 
micronucleus assay; Moquet et al. (2016) for the gamma-H2AX assay and Terzoudi et 
al. (2016) for the PCC assay. The results of the most recent RENEB table-top exercise 
demonstrated a very good agreement between laboratories, with a mean categorization 
accuracy (defined as the number of triage categorisation answers which were the same 
as the default values, divided by the number of all answers) of 95% throughout the 
entire exercise (Brzozowska et al., 2016). 
A large amount of work has shown that analysis of the number of dicentrics in 
50 cells is sufficient for this purpose (e.g. Romm et al., 2013) and thus, for the 
comparisons within study, 50 cells was chosen for all assays. However, it should be 
  
noted that recommendations differ between the assays. For the micronucleus assay, a 
larger number of approximately 200 cells is required (Thierens et al., 2014); for 
gamma-H2AX and PCC, 20 – 30 cells may be sufficient (Barnard et al., 2015; 
Karachristou et al., 2015). However, while uncertainties have been analysed in order to 
provide an indication of the number of cells that might result in a suitably reliable dose 
estimate, the impact of uncertainty on the rapid biodosimetry categorization results has 
not been considered.  
In this work, a number of different methods of calculation of uncertainty for 
biodosimetry dose estimates have been assessed and compared: A method based on the 
ISO standard methodology; the MULTIBIODOSE simplification of this method 
ignoring the covariance terms; a method to incorporate Poisson uncertainty on the yield 
of aberrations with the error on the calibration curve; one other of the suggested 
methods from the IAEA manual (which, in practice, is what many laboratories are 
currently using), and a method based on Bayesian assessment of the prior dose and 
calibration data to produce a posterior ‘calibrative density’ dose distribution which fully 
incorporates all the uncertainty contributions. In practical terms, the differences in 
magnitudes of calculated uncertainties between the methods are generally small. Indeed, 
the simulation results in Table II demonstrate that the most accurate methodology, 
assessed by the magnitude of the confidence limits, depends on the dose and the number 
of cells. The Bayesian methodology of Higueras and colleagues (2015) is the most 
accurate at a relatively low dose of 0.5 Gy for dose assessments in both the routine 
(~200 – 2000 cell) and rapid (50 cell) dosimetry scenarios. For the highest dose of 3 Gy, 
the Merkle method gave the most accurate coverage, and for the intermediate chosen 
dose of 1.5 Gy, the ISO/MBD methods were the most successful. The 
MULTIBIODOSE simplification provides more conservative dose estimation 
  
uncertainties than the ISO method, due to the fact that the largest covariance of the 
calibration curve fitting is negative (Table I). The IAEA simplification is not always 
conservative, in contrast to the more detailed Merkle methodology which includes both 
scoring uncertainty and error on the curve coefficients (IAEA 2011; Higueras, 2015), 
and thus which results in the largest uncertainties. 
Further, Table III and Figure 3 demonstrate that when the uncertainty on dose is 
accounted for by assigning categories based on probability, albeit in a very simplified 
manner, it is possible that an incorrect categorization may result.  For instance, Figure 3 
demonstrates that at 1 Gy, as might be expected, there is a probability of approximately 
50% that the estimated dose would be placed in the < 1 Gy category and approximately 
45% that the dose would be placed in the 1 – 2 Gy category. This highlights the 
qualitative nature of such categorisation. For the ISO, MBD, IAEA and Merkle 
methodologies, the method of accounting for uncertainty in this publication, by relying 
on the standard normal distribution, is rather simplistic as the aim is to demonstrate that 
uncertainty may have a more important role than has previously been considered for 
emergency biodosimetry. In addition, the R2 regression confidence factor 
(corresponding to the confidence limit of the chi-square distribution) was chosen as 7.81 
for 95% coverage (IAEA, 2011). However, some authors have suggested that for the 
Merkle method, this results in overestimation of the uncertainty, and thus a lower 
coverage factor should be applied (IAEA, 2011). This requires further investigation.  
General considerations for uncertainty for biodosimetry have recently been 
addressed by several authors (e.g. Szluinska et al., 2007; Vinnikov et al., 2010). Several 
publications have demonstrated that distributions other than the Poisson may be more 
applicable to yields of chromosome aberrations (e.g. Ainsbury et al., 2013; Higueras et 
al., 2015; Oliveira et al., 2016), for example, and thus it is possible that radiation dose 
  
estimates may be more accurately described by alternative distributions to the Poisson. 
The Bayesian approach allows much more accurate characterisation of the dose 
distribution as it is based on the combined information regarding the potential dose and 
exposure scenario, the calibration coefficients and the yield of aberrations. It should be 
noted that in some circumstances, the Bayes method applied here, as illustrated in Table 
III, gives the lowest probability of the ‘correct’ categorisation. This stems from the fact 
that the Bayesian approach intrinsically incorporates the prior information provided and, 
in this case the least informative approach to Bayesian calculations was also taken here: 
using an improper uniform dose prior which would be applied in a real life situation if 
there was no prior dose information available (as does sometimes occur). A more 
sophisticated analysis based on more appropriate priors for the specific exposure 
scenario should yield much improved results in real life analyses. 
An additional limitation of this study is that only a small amount of data has 
been tested, and in most cases simplified assumptions have been applied – for instance 
the use of 50 cells, an exposure time of 10 hours and a t0 of 2 hours throughout. For the 
gamma-H2AX assay in particular, although the idea to include a reference sample as a 
positive control has been incorporated into the uncertainty calculations, several 
additional experimental variables have been ignored. For instance, in a real life accident 
exposure scenario, it is highly unlikely that samples would be taken after exactly 4 or 24 
hours, thus a correction for time should also be included. Indeed, in practice, the 
uncertainty imparted as a result of all the additional experimental factors needs further 
consideration in order that these can be fully incorporated into the uncertainty budget.  
Further, while the ISO recommendations for uncertainty characterisation, based 
on propagation of errors, can readily be applied to the full range of assays and exposure 
scenarios explored in this manuscript, the IAEA manual methods are geared towards 
  
dicentric analysis following only one specific scenario of acute, high dose rate, low 
linear energy transfer exposures up to approximately 5 Gy (i.e. those resulting in well-
defined linear quadratic dose response relationships up to the ‘saturation dose’; IAEA 
2011). While these methods were judged to be applicable for the micronucleus assay, 
and have thus been applied here for both assays in the HDR scenario, it was not judged 
to be suitable for the other scenarios and assays included in this manuscript. Further 
work would be required to develop similar simplified methodologies for the gamma-
H2AX and PCC assays and for chronic exposures. Also for partial body exposures, 
which have not been considered in this manuscript. 
The calibration curves, assays and exposure scenarios analysed in this work 
were chosen in an attempt to sample a wide range of potential situations in which 
dosimetry might be required. This includes taking a manually scored dicentric curve 
(i.e. one created by eye rather than by automated dicentric detection) and applying it in 
acute and chronic exposure scenarios; an automated micronucleus assay curve applied 
similarly; applying the gamma-H2AX assay for dose assessment at 4 and 24 hours, and 
comparing all these with the PCC assay methodology used in RENEB (Terzoudi et al., 
2016). Nevertheless, further work will be required to fully assess the impact of all 
experimental variables in the full range of potential exposure scenarios on the 
magnitude of the uncertainty. The uncertainties for the additional RENEB/EURADOS 
operational assays – EPR and OSL - should also be considered in detail, as should those 
for the newer methods such as thermoluminescence spectroscopy and gene expression 
which are now being tested and validated (Ainsbury et al., 2016). The obvious place for 
this work and the associated biological and physical development would be as part of 
RENEB / EURADOS joint exercises going forward. 
  
Overall, in terms of impact on rapid biodosimetry categorization, the results 
from the RENEB accident simulation exercise show that inclusion of uncertainty has a 
relatively low impact. However, for doses between ~ 1.7 and 2 Gy (within the 
assumptions of this study), it is possible that individuals may be incorrectly categorised 
as being of 2 Gy or higher and, more importantly from a medical point of view, for 
exposures just above 1 Gy there is a clear risk of miscategorisation as a 0 – 1 Gy event. 
While the above results show that the probability of misclassification increases towards 
the categorization boundaries (i.e. close to 1 or 2 Gy), a sensible approach in any case 
might be to check the positions of the 95% confidence limits which will give an 
indication of the likelihood that the dose and category have been correctly assigned. 
It is undoubtedly hugely important for practising members of the international 
biodosimetry community to have a good grasp of the uncertainties associated with dose 
estimates in both routine and emergency response scenarios. This comparison of 
methods has thus been useful in providing a benchmark for the likely levels of 
uncertainty that will be observed, albeit with the limitations listed above. However, an 
important point for consideration is whether it will be possible to include the uncertainty 
estimates in the rapid biodosimetry categorization procedure and, further, whether the 
medical professionals to whom the dose information will be provided will be interested 
in the accuracy of the results. The first part of this question was considered in part 
during the MULTIBIODOSE final biodosimetry triage categorisation exercise. The 
results showed that, considering dose alone, approximately 70% of samples  were 
correctly categorised. However, it was found that incorporating uncertainty estimates 
into the analysis did not improve dose categorization results, rather the opposite 
(Ainsbury et al., 2014). For the second part of the question, the current consensus 
within the field is that in a radiation emergency, the acute phase responders will not 
  
have time to deal with uncertainty estimates in addition to dose estimates; rather it will 
be sufficient to say that the retrospective dosimetry estimates provided are highly 
uncertain, but are the best that can be done given the constraints of acting in fast 
assessment mode. However, to the knowledge of the authors, this has not yet been 
discussed in detail with the relevant stakeholders, and thus further work to clarify the 
related issues will be essential before further development can take place. 
Conclusions 
Four methods of uncertainty estimation for radiation biodosimetry have been tested and 
compared. As expected, the Bayesian approach detailed in this publication intrinsically 
provides the most complete assessment of dose in the form of a posterior probability 
distribution. However, the approaches recommended by the ISO standard, the IAEA 
manual (including the Merkle methodology) and the simplified MBD version were 
comparable in their performance and thus all methods have both been shown to 
characterise uncertainty reasonably well for the purposes of retrospective dosimetry to 
support emergency response.  
The results of this work highlight the importance of accurate characterisation of 
dose uncertainties, which can directly impact rapid biodosimetry categorization of 
suspected exposed individuals. However, the practical implications of incorporating 
assessment of uncertainty into fast assessment results provided to medical professionals 
need to be further considered. 
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Tables 
 
Table I. Calibration curve coefficients and covariances, calculated using R (2014), for 
the four biodosimetry assays. *This value was taken as 0 for further analyses. 
 
 
   
Coefficients 
Assay Data Scenario A α β cov α β cov α A cov A β 
Dicentric 
Barquinero 
et al., 1995 
HDR/LDR 
0.0013 +/- 
0.0005 
0.0216 +/- 
0.0052 
0.0621 +/- 
0.0039 
-1.49E-05 -9.83E-07 4.25E-07 
Micronucleus 
Thierens et 
al., 2014 
HDR/LDR 
0.0316 +/- 
0.0045 
0.0631 +/- 
0.0083 
0.0110 +/- 
0.0022 
-1.73E-05 -2.58E-05 5.42E-06 
Gamma-
H2AX 
Rothkamm 
et al., 2014 
HDR 4 hr 
0.6454 +/- 
0.0822 
2.4686 +/- 
0.0676 
- - -2.90E-03 - 
HDR 24 hr 
0.1060 +/- 
0.0379 
0.8227 +/- 
0.0455 
- - -7.57E-04 - 
PCC 
Terzoudi et 
al., 2016 
HDR 
3.465E-10 +/- 
4.094E-6* 
1.1978 +/- 
0.0295 
- - -3.66E-12 - 
 
 
 
 
 
 
 
 
 
 
 
  
Table II. Non-parametric bootstrap simulation of dicentric assay results to assess the 
magnitude of the confidence limits actually covered for a desired confidence level of 
95%. The most accurate confidence (credible) region values for each experiment, those 
closer to 95%, are given in bold. *830 samples were excluded, due to resulting negative 
values for the square root term applying equation (1)." 
equation (1). 
 
Dose, 
Gy 
Method Cells 
Coverage, 
% 
Cells 
Coverage, 
% 
0.5 
ISO 
2002 
94.47 
50 
80.68* 
MBD 96.94 80.52* 
IAEA 92.05 98.86 
Merkle 99.88 99.52 
Bayes 94.68 97.14 
1.5 
ISO 
562 
94.03 
50 
93.81 
MBD 96.81 94.23 
IAEA 92.51 95.86 
Merkle 99.40 98.14 
Bayes 93.53 93.90 
3.0 
ISO 
193 
67.71 
50 
87.77 
MBD 74.22 88.65 
IAEA 63.96 90.56 
Merkle 96.53 97.98 
Bayes 71.84 90.10 
 
 
 
 
 
 
 
 
  
Table III. Cumulative normal (ISO, IAEA, Merkle and MBD) or Bayesian posterior 
probabilities of being in correct triage category, given calculated uncertainties, for 
simulated doses of 0, 0.5, 1, 1.5, 2 and 2.5 Gy. 
 
 
   
Actual dose 
Assay 
Exposure 
details 
Method 0 Gy 0.5 Gy 1 Gy 1.5 Gy 2 Gy 2.5 Gy 
Dicentric 
HDR 
ISO 1.000 0.962 0.500 0.921 0.500 0.958 
IAEA 1.000 0.990 0.500 0.949 0.500 0.969 
Merkle 1.000 0.980 0.500 0.898 0.499 0.924 
MBD 1.000 0.962 0.500 0.917 0.500 0.955 
Bayes 0.996 0.962 0.513 0.917 0.444 0.965 
LDR 
ISO 1.000 0.987 0.500 0.971 0.500 0.983 
MBD 1.000 0.986 0.500 0.970 0.500 0.982 
Bayes 0.934 0.739 0.470 0.697 0.488 0.867 
Micronucleus 
HDR 
ISO 0.993 0.845 0.500 0.616 0.453 0.794 
IAEA 0.999 0.884 0.500 0.670 0.468 0.814 
Merkle 1.000 0.876 0.500 0.608 0.447 0.776 
MBD 0.993 0.843 0.500 0.603 0.447 0.781 
Bayes 0.966 0.791 0.483 0.608 0.448 0.830 
LDR 
ISO 0.993 0.861 0.500 0.685 0.476 0.836 
MBD 0.993 0.862 0.500 0.679 0.473 0.827 
Bayes 0.903 0.713 0.385 0.508 0.349 0.822 
gamma-
H2AX 
4 h 
ISO 1.000 0.998 0.500 0.712 0.447 0.742 
MBD 1.000 0.998 0.500 0.714 0.447 0.742 
Bayes 1.000 1.000 0.469 1.000 0.484 1.000 
24 h 
ISO 1.000 0.993 0.500 0.678 0.462 0.732 
MBD 1.000 0.993 0.500 0.682 0.436 0.733 
Bayes 1.000 0.999 0.481 0.975 0.447 0.978 
PCC HDR 
ISO 1.000 1.000 0.500 0.998 0.500 0.990 
MBD 1.000 1.000 0.500 0.998 0.500 0.990 
Bayes 1.000 1.000 0.458 0.996 0.466 0.996 
 
 
  
  
Figures 
Figure 1. Comparison of standard deviations based on simulated chromosome 
aberration data for doses of 0, 0.5, 1, 1.5, 2 and 2.5 Gy using the MBD method for the 
four assays: bold dotted line – DIC; solid line – MN; bold dashed line – gamma-H2AX; 
bold solid line – PCC. 
 
 
 
 
 
 
 
  
Figure 2. Example normalised posterior dose distribution (‘calibrative density’) for a 
simulated HDR exposure resulting in a yield of 0.17 dicentrics per cell to give a 
nominal dose of 1.5 Gy. The expected dose is 1.53 +/- 0.28. The probability of being in 
between 1 and 2 Gy (shaded in grey) is calculated as 0.917. 
 
 
 
 
 
 
  
Figure 3. Cumulative probability of correct categorization – probability that a dose is 
placed in the category 0 – 1 Gy (solid line), 1 – 2 Gy (dashed line) or 2 + Gy (dotted 
line). 
 
 
 
